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Abstract
Alcohol dependent smokers (N = 118) enrolled in an intensive outpatient substance abuse treatment
program were randomized to a concurrent brief or intensive smoking cessation intervention. Brief
treatment consisted of a 15-minute counseling session with 5 min follow-up. Intensive intervention
consisted of three one-hour counseling sessions plus eight weeks of nicotine patch therapy. The
cigarette abstinence rate, verified by breath CO, was significantly higher for intensive (27.5%) versus
brief (6.6%) treatment at one month post quit date but not at six months when abstinence rates fell
to 9.1% and 2.1%. Smoking treatment assignment did not significantly impact alcohol outcomes.
Although intensive smoking treatment was associated with higher rates of short term tobacco
abstinence, other, perhaps more intensive smoking interventions are needed to produce lasting
smoking cessation in alcohol dependent smokers.
Keywords
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Although cigarette smoking prevalence among U.S. adults has declined to 21 percent (Centers
for Disease Control and Prevention, 2005), the majority of individuals with alcohol problems
remain current smokers (Hughes, 1995; Lasser et al., 2000). The Department of Health and
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Human Services (DHHS) Clinical Guidelines for Treating Tobacco Use and Dependence
provided a consensus recommendation that smokers receiving treatment for chemical
dependency should be provided smoking cessation treatments including both counseling and
pharmacotherapy (Fiore, Bailey, Cohen et al., 2000). However, the Guideline panel noted that
that this recommendation was made in the absence of definitive randomized clinical trials.
Most community-based treatment settings offer no smoking cessation intervention at all (Fuller
et al., in press). A brief counseling intervention such as recommended by the Agency for
Healthcare Policy and Research (Smoking Cessation Clinical Guideline Panel & Staff, 1996)
may be the most feasible approach in these settings. However, this brief counseling approach
may be inadequate in light of research that indicates a strong dose-response relationship
between the amount of clinician contact time and successful treatment outcome. Additionally,
the most successful of the concurrent alcohol-tobacco treatment trials included nicotine
replacement as a component (Cooney, Cooney, Patten, & George, 2004). A recent review
(Hughes and Kalman, 2006) found consistent evidence that comorbid alcohol problems were
associated with more severe nicotine dependence, suggesting that those with alcohol problems
might have a greater need for intensive smoking intervention. The present study was designed
to compare brief smoking cessation counseling with a more intensive intervention that
incorporated two of the DHHS practice guidelines recommendations, extended clinician
contact time and pharmacotherapy for smoking cessation.
An additional concern is that concurrent alcohol and smoking cessation treatment will increase
risk of alcohol relapse. With the possible exception of a study by Joseph et al. (2004), this has
not seemed to occur (e.g., Hurt et al., 1994; Burling et al., 1991; Burling et al., 2001; Bobo et
al., 1995, 1998). Inconsistencies among outcome studies, however, suggest a need for further
evaluation of concurrent smoking cessation treatment on alcohol treatment outcome.
The primary aim of this article was to report the outcome of a randomized clinical trial that
tested the hypothesis that a smoking cessation intervention consisting of intensive behavioral
counseling and nicotine patch therapy will lead to greater short and long-term smoking
abstinence compared with a brief smoking cessation advice condition. A second aim was to
determine whether there was any effect of the intensive smoking intervention on drinking
outcomes. Unlike prior studies of concurrent treatment, this study was conducted in an
outpatient setting because it is often the preferred setting for alcohol treatment for patients with
sufficient social resources and without serious medical or psychiatric impairment (Finney,
Hahn, & Moos, 1996).
Method
Participants
Methodological details for this study are reported in Cooney, Litt, Cooney, Pilkey, Steinberg,
and Oncken (in press). Participants were recruited from two VA substance abuse intensive
outpatient programs with ten non-veteran women recruited from the community for the purpose
of gaining a more diverse sample. Participants had to be at least 18 years old, meet DSM-IV
criteria for alcohol and nicotine dependence during the past three months, and smoke at least
ten cigarettes per day. Exclusion criteria were diagnosis of current opioid dependence, current
cannabis abuse or dependence, and current intravenous drug use, with additional criteria
described in Cooney et al. (in press). Participant flow is described in Figure 1. This report was
based on the 118 participants exposed to brief (n = 63) or intensive (n = 55) smoking cessation
treatment. The study was powered to detect moderate (i.e., d = .3) differences between smoking
cessation treatment conditions.
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Design and Procedure
The substance abuse intensive outpatient program provided an initial rehabilitation treatment
for substance abusers, utilizing a cognitive-behavioral coping skills approach (Monti, Kadden,
Rohsenow, Cooney, & Abrams, 2002). Length of stay in the program was three weeks with
program meetings five days per week. Urine and breath were monitored for drug and alcohol
use at random intervals during treatment. Participants completed baseline assessment measures
and were randomized to either (a) intensive smoking cessation treatment consisting of
behavioral counseling and transdermal nicotine replacement, or (b) brief smoking cessation
advice without nicotine replacement. During the 14 days immediately after discharge from the
substance abuse intensive outpatient program, all participants were asked to participate in an
Ecological Momentary Assessment protocol (reported in Cooney et al., in press).
Intensive smoking cessation treatment condition—Behavioral smoking cessation
counseling was administered in three 60-minute individual sessions. The manual-guided
behavioral counseling protocol followed DHHS practice guidelines (Fiore et al, 2000). The
intensity of this intervention protocol was similar to that used by Joseph et al (2004). Content
of counseling sessions included setting a targeted quit date, identification of antecedents for
smoking urges and behavior, development of behavioral and cognitive coping skills for high
risk smoking situations, and acquisition of extra-treatment support for smoking cessation.
Treatment was delivered by masters or doctoral level clinicians with experience in behavioral
smoking cessation treatments. Smoking quit dates were scheduled approximately one week
into the three-week substance abuse treatment program. On the scheduled quit date, participants
were provided a free four-week supply of 21 mg Nicoderm© transdermal patches, followed
by free prescriptions for two weeks at 14 mg, and two weeks at 7 mg.
Brief smoking cessation advice condition—The brief advice intervention was based
on protocols developed by the National Cancer Institute (Glynn & Manley, 1991) and
recommended by the Agency for Healthcare Policy and Research (Smoking Cessation Clinical
Guideline Panel & Staff, 1996). The smoking cessation therapist saw participants for one
fifteen-minute session to ask about smoking status and smoking rate, advise the participant to
quit smoking, assist in quitting through setting a quit date within one week and giving cessation
tips, and arrange for a brief 5-minute follow-up appointment within three days of the quit date.
Nicotine replacement was not offered to participants in this condition.
Assessment—Alcohol and cigarette consumption was measured using the Form 90 (Miller
& Del Boca, 1994) administered at baseline and at scheduled research follow-up interviews
14-days, 3-months, and 6-months after discharge from the substance abuse outpatient program.
Note that this research follow-up schedule translates to 1 month, 3.5 months, and 6.5 months
after the target smoking quit date which was two weeks before program discharge. However,
unless otherwise noted, follow-up timing will be designated with reference to time since
substance abuse program discharge. Participants were paid $15 for participation in the baseline
and first follow-up assessments, and $50 for the second and third follow-up assessments.
Two drinking dependent measures were derived from the Form-90 data collected at each time
point. The first of these, Proportion Days Heavy drinking (PDH), reflected the proportion of
days of heavy drinking in the 14 days prior to the 14-day follow-up (the time since program
discharge) and in the 30 days prior to the 3 and 6-month follow-ups. A heavy drinking day was
defined as any day on which a man drank six or more standard drinks or a woman drank four
or more standard drinks. The second measure was a dichotomous variable reflecting reported
alcohol abstinence throughout the 14 or 30 days prior to a follow-up point. Two smoking
dependent measures were also examined. One was repeated 7-day point prevalence smoking
abstinence at each of the three scheduled follow-ups, verified by breath carbon monoxide (CO)
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levels of < 10 parts per million. The second measure was time to relapse, computed from the
patient's smoking quit day to the day of the first cigarette in the 180 day follow-up period.
These smoking outcome measures were selected because they provide biochemically verifiable
measures of reported abstinence over time (Hughes, Keely, Niaura, Ossip-Klein, Richmond,
& Swan, 2003).
Results
The sample (N = 118) was 89% male and 11% female. The mean age was 46.6 years (± 7.8
years). Race was 65.5% White, 30.2% Black, 1.7% Hispanic, and 2.6% other. Seventy five
percent of the participants were unemployed and 25.4% were married or were living with a
spouse or partner. All met DSM-IV criteria for Alcohol and Nicotine Dependence, drank on a
mean of 61% of the days in the 3 months prior to seeking treatment at the VA, and consumed
an average of 19.3 (± 17.1) alcoholic drinks per day. They reported a mean of 4.2 prior
treatments for alcohol problems (SD = 9.1). Participants smoked a mean of 98% of days and
a mean of 24.8 cigarettes (SD = 9.9) per day during the three months prior to seeking treatment.
The mean Fagerström Test for Nicotine Dependence (Heatherton, Kozlowski, Frecker, &
Fagerström, 1991) score was 5.5 (± 2.2). They reported smoking for a mean of 28.1 years
(SD = 10.0) and attempted to quit a mean of 3.8 times (SD = 4.8). Participants met criteria for
lifetime other substance abuse or dependence as follows: cocaine (32.3%), opioid (10.4%),
cannabis (19.8%), stimulant (10.4%), hallucinogen (4.1%), and sedative/hypnotic/anxiolytic
(6.3%). Multiple t-tests and chi-square analyses were used determine if the two treatment
groups were homogeneous with respect to background variables. Variables examined were
sex, age, ethnicity, education, employment status, baseline number of drinks consumed per
day, number of smoking quit attempts, cigarettes smoked per day, and baseline Fagerström
nicotine dependence score. Analyses indicated that the groups were equivalent on all baseline
measures.
All of the study sample completed the intensive outpatient substance abuse program and were
exposed to smoking cessation behavioral counseling. Among the twelve participants verified
abstinent from smoking four weeks after quit date, ten were prescribed the initial four weeks
of nicotine patches and nine were provided nicotine patch renewals.
Form 90 data were obtained for 99.2% of cases at the 14-day follow-up, 87.3% at the 3-month
follow-up, and 80.5% of cases at the 6-month follow-up. An additional 3 to 4% of cases were
lost for the smoking outcome due to missing carbon monoxide (CO) data. Attrition rates for
the 3 and 6-month follow-ups were moderately higher in the Brief treatment condition than in
the Intensive treatment condition (see Figure 1). A comparison of those who were lost to those
who remained in the study, however, showed that their early smoking quit rates were similar
[20% abstinence at 14 days among those lost, compared to 15.5% abstinence among those who
remained [N=112; χ2(1)= 0.20, p > .6], suggesting that follow-up attrition was not due to poorer
smoking outcomes.
Analysis of Smoking Outcomes
Seven-day point prevalence smoking abstinence rates (CO-verified) for each follow-up point
are shown in Table 1. To evaluate the influence of smoking cessation treatment Condition on
abstinence from smoking over time, a generalized estimating equations (GEE) approach was
used (Proc GENMOD, SAS Institute, 1999). Time was modeled as a repeated measure, and
scaled as days since baseline (i.e., 14, 90, and 180 days). An autoregressive (AR1) covariance
structure produced the best fit in modeling the repeated indicators of abstinence. The analysis
yielded no significant effect for smoking cessation treatment Condition on smoking abstinence,
and no interaction of Time X Condition. A significant effect for Time did emerge (βTime =
-4.86; se = 0.74; N = 118; χ2(2) = 2.03; p < .05; RR = .007; CI = 0.002 to 0.03). Examination
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of abstinence rates by time period indicated that abstinence rates decreased over time. Chi-
square tests at each time point did show a significantly higher cigarette abstinence rate for the
Intensive treatment at the 14-day posttreatment time point. Note that this was one month after
target smoking quit date.
Cox regression analysis was conducted on time to relapse by smoking cessation treatment
condition. Time to relapse was computed from the patient's quit day to the day of the first
cigarette out to 180 days post alcohol treatment discharge. Results showed no effect for
smoking treatment condition on survival. Mean days of abstinence among those who quit were
16.2 (SD = 37.6) for Brief versus 22.6 (SD = 37.0) for Intensive [F(1, 85) = 0.62, ns].
Analysis of Drinking Outcomes
Mean PDH and alcohol abstinence rates based on available data by smoking cessation treatment
condition are shown in Tables 2 and 3. Analysis of PDH was conducted using a 2 (treatment
condition) X 3 (Time period: 14 days; 3 months; 6 months) linear mixed model regression
procedure with the baseline value of PDH used as a covariate (Proc MIXED, SAS Institute,
1999). PDH was arcsine transformed to correct for the skewness of the proportion data (Winer,
1971). The analysis yielded a significant main effect for Time [F(2, 194) = 4.94; p < .01], but
no significant main effect for treatment Condition or for the interaction of Condition X Time.
Examination of least squared means indicated that PDH increased slightly over time from the
14-day point to the 6-month follow-up.
Rates of abstinence from drinking for the time period prior to each follow-up point are shown
in Table 3. As in the mixed model analysis described above for smoking quit rates, a GEE
approach with an autoregressive covariance structure was used. Abstinence rate at baseline
was used as a covariate. The analysis yielded no significant effect for smoking cessation
treatment Condition on drinking abstinence, and no interaction of Time X Condition. A
significant Time effect emerged, such that longer time from baseline was associated with less
abstinence (βtime = -1.47; se = 0.32; N = 118; χ2(3) = 21.27; p < .001; RR=.23; CI = 0.12 to
0.43).
Relationship between smoking and drinking outcomes
Among those assessed at the 14 day follow-up, across both treatment groups, 16% of
participants reported not smoking and not drinking, with 76% of participants reporting they
were smoking and not drinking. All participants who reported drinking also reported current
smoking (8% of the full sample). These results suggest that maintenance of abstinence from
alcohol was necessary but not sufficient for maintenance of abstinence from tobacco in the
initial follow-up period. There was not enough variability in smoking outcome in the later
follow-ups to examine the relationship between long-term smoking and drinking outcomes.
Discussion
This study examined treatment outcome after concurrent alcohol and smoking cessation
treatment. The alcohol outcomes were reasonably good, and comparable to those reported in
Project MATCH (Babor et al., 2003), with approximately 60% reporting at least 30 days
continuous abstinence at the six month follow-up. The intensive smoking treatment was
associated with good treatment exposure, good nicotine patch compliance, and higher short-
term tobacco abstinence. However, the long-term smoking outcome results were disappointing.
Six months after treatment only 9.1% were confirmed abstinent in the intensive treatment
condition. This is much lower than the 17% abstinence rate reported in a review of studies of
nonalcoholic smokers on nicotine patch therapy (Fiore et al, 2000), but is within the range of
what is usually seen in studies of concurrent alcohol tobacco treatment (Burling, Marshall &
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Seidner, 1991; Bobo et al., 1995, 1998; Joseph, Nichol, & Anderson, 1993). Higher cigarette
abstinence rates have been reported in studies that employed far more intensive smoking
interventions (Hurt et al., 1994; Burling, Burling, & Latini, 2001). Taken together, these data
suggest that alcohol dependent smokers currently in treatment for alcohol problems have more
difficulty quitting than those without alcohol problems. A smoking cessation intervention more
intensive than the one employed in this study may be needed for effective smoking cessation
during alcohol treatment.
Compared to the brief treatment that produced minimal smoking cessation, there appears to be
no negative effect of concurrent intensive smoking cessation treatment on drinking soon after
treatment or six months later. However, a more effective smoking cessation intervention is
required to provide a stronger test of positive or negative carryover effects from smoking
cessation to drinking. The lack of any negative carryover effect found here is consistent with
earlier research (Hurt et al., 1994; Burling et al., 1991; Burling et al., 2001; Bobo et al.,
1995, 1998). However, the present results are not consistent with the methodologically strong
study reported by Joseph et al. (2004) which found worse alcohol outcomes after concurrent
alcohol tobacco treatment, in comparison to a condition in which smoking cessation was
delayed six months. It is possible in that study that the process of anticipating and then
participating in a four-session smoking cessation intervention six months after alcohol
treatment acted as a booster alcohol treatment leading to better alcohol outcomes, even prior
to the onset of the delayed smoking treatment, relative to the concurrent alcohol tobacco
condition which had no further treatment during the follow-up phase.
Study Limitations
This design was selected with the aim of maximizing the contrast between brief and intensive
smoking cessation interventions in a way that could be readily applied during intensive
outpatient alcohol treatment. This design, however, did not allow one to parse out the separate
effects of intensity of behavioral counseling and nicotine patch therapy. Also, the manipulation
of patch therapy was not placebo controlled and the manipulation of behavioral counseling
intensity did not allow inferences regarding the impact of specific content of treatment.
Almost 90% of the individuals screened for this study were not eligible or did not enroll. This
is in part because we cast a wide net, screening many who were not eligible. A relatively small
number of eligible individuals (26 percent) declined participation, suggesting that there is
significant interest in concurrent smoking cessation among those in alcohol treatment. Women
were underrepresented in the sample, so generalization of our findings to women should be
done with caution. The sample size of this trial limits our ability to detect small effects on
smoking and drinking outcomes.
In conclusion, results of this trial suggest that low or moderate intensity smoking interventions
delivered concurrent with alcohol treatment are unlikely to produce much long-term smoking
abstinence. Without high smoking abstinence rates, one cannot provide a strong test of the
impact of smoking cessation on alcohol outcomes. Future concurrent alcohol-tobacco
treatment trials should consider more intensive smoking interventions such as a combination
of medications, frequent behavioral counseling or contingency management.
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Figure 1.
Participant flow diagram.
* These numbers are estimated because screening data was available for only a subset of 198
individuals.
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